New York-based life sciences and materials science company Schrödinger, Inc. (NASDAQ: SDGR) has acquired Boston-based structural biology services provider XTAL BioStructures, Inc. to expand Schrödinger's position in structure-based drug discovery, the company said.
Schrödinger and XTAL BioStructures closed the USD 6m all-cash acquisition on January 14, 2022, and XTAL BioStructures is now operating as part of Schrödinger.
Health Catalyst Acquires Armus to Enhance Outsourced Services Offerings
Concentric Acquires Mesa Technical Associates to Expand Footprint in Northeast
UNS Acquires CyberPeak Solutions to Expand Cybersecurity Offerings
Modus Create Acquires Atlas Authority to Expand Team of Atlassian Services Providers
Alira Health Acquires RedCrow to Extend Healthcare Focussed Financing Opportunities
Easterly government Properties Acquires Colorado-Based National Archives and Records Center
ICE Global Consulting Merges with CliniStart to Expand Services in Clinical Research Contracting
Axiologic Solutions Acquires Data Intelligence Technologies to Expand IC Portfolio
Spacer Technologies Acquires WhereiPark to Monetise Existing Assets in Sharing Economy
VeriSIM Life Acquires Spanish Drug Discovery Firm Molomics Biotech
Carsharing Marketplace Getaround to Go Public via Merger with SPAC
Arklyz Acquires European Sneakers and Streetwear Seller Asphaltgold
SilverBow Resources Closes USD 71m Acquisition of Oil and Gas Firm SandPoint
Relation Insurance Services Acquires the Assets of The Wills Agency
Principal Shareholders of Avianca, Controlling Shareholder of GOL to Create Abra Group